Avirex Pharma Private Limited
About Avirex Pharma Private Limited
Data last updated:
Avirex Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 08 July 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2022PTC386372.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Archana Singh and Vijay Kumar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G/204 B Wing Express Zone Mall Next To Patel Vanika Goregaon East, Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.03 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹20.94 Lakh (net margin 1.6%) and EBITDA of ₹28.4 Lakh (EBITDA margin 2.2%).
Company details
Contact details
Avirex Pharma Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressG/204 B Wing Express Zone Mall Next To Patel Vanika Goregaon East, Mumbai, Maharashtra, India – 400063
- IndustryChemicals, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Avirex Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Avirex Pharma Private Limited, buy the company report.
Financials of Avirex Pharma Private Limited
FY 2025 filings availableAvirex Pharma Private Limited reported revenue of ₹13.03 Cr (up 654% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 654% in the latest year. EBITDA rose 105% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹28.4 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹20.94 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.2% | |
| Net Profit Margin | 1.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Avirex Pharma Private Limited, buy the company report.
Board of directors of Avirex Pharma Private Limited
Avirex Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Archana Singh | Director | 06 Jun 2024 | 2 Years 4 Months | Current |
| Vijay Kumar Gupta | Director | 08 Jul 2022 | 4 Years 3 Months | Current |
| Ujjwal Singh Baghel | Director | 13 Jun 2025 | 1 Years 4 Months | Current |
Peer comparison
Avirex Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chroma Dyechem Private Limited | ₹13.05 Cr (FY 2025) | 47.0% | Vadodara, Gujarat, India | |||
| The Circus Entertainment Private Limited | ₹13.05 Cr (FY 2019) | New Delhi, Delhi, India | ||||
| Theraoral Care Products Private Limited | ₹13.05 Cr (FY 2024) | Ahmedabad, Gujarat, India | ||||
| Shamlax Meta Chem Private Limited | ₹13.04 Cr (FY 2025) | 13.0% | Nagpur, Maharashtra, India | |||
| Meddoxx Pharmaceuticals Private Limited | ₹13.03 Cr (FY 2025) | 14.0% | Kozhikode, Kerala, India | |||
| Avirex Pharma Private Limitedthis company | ₹13.03 Cr (FY 2024) | ₹20.94 Lakh | 1.6% | 654.0% | Mumbai, Maharashtra, India | |
| Harmony Additives Private Limited. | ₹13.02 Cr (FY 2025) | 15.0% | Mumbai, Maharashtra, India | |||
| Karanwal Lime Chem (I) Private Limited | ₹13 Cr (FY 2024) | -6.0% | Uttar Pradesh, India | |||
| Biocon Biosphere Limited | ₹13 Cr (FY 2025) | 2067.0% | Bengaluru, Karnataka, India | |||
| Associated Pharma Traders Pvt. Ltd. | ₹13 Cr (FY 2025) | 0.0% | Rajasthan, India | |||
| Aster Medicines Private Limited | ₹13 Cr (FY 2025) | 20.0% | Patna, Bihar, India |
To see the full peer comparison of Avirex Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Avirex Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avirex Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Avirex Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Avirex Pharma Private Limited has 5 board changes on record since 2022: 3 appointments and 2 cessations. The latest: Archana Singh ceased to be Director on 14 Jun 2025.
Frequently asked questions
Avirex Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 08 July 2022 (4+ years old) and is registered under CIN U24100MH2022PTC386372.
Avirex Pharma has 3 current directors:
- Archana Singh - Director
- Vijay Kumar Gupta - Director
- Ujjwal Singh Baghel - Director
The latest financial statements of Avirex Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Avirex Pharma is U24100MH2022PTC386372. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avirex Pharma was incorporated on 08 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Avirex Pharma by revenue are Chroma Dyechem Private Limited, The Circus Entertainment Private Limited, Theraoral Care Products Private Limited, Shamlax Meta Chem Private Limited, Meddoxx Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Archana Singh ceased to be Director on 14 Jun 2025. Ujjwal Singh Baghel was appointed as Director on 13 Jun 2025. Rudra Pratap Singh ceased to be Director on 07 Jun 2024. Avirex Pharma has 5 board changes on record in total.
The registered office of Avirex Pharma is at G204 B Wing Express Zone Mall Next To Patel Vanika Goregaon East, Mumbai, Maharashtra, India – 400063.
Avirex Pharma operates in the chemicals industry, in the manufacturing segment.
Avirex Pharma can be reached at its registered office: G204 B Wing Express Zone Mall Next To Patel Vanika Goregaon East, Mumbai, Maharashtra, India – 400063.
Avirex Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.